US STOCK
PRAX Stock Analysis
US stocks · market data · technical indicators
Praxis Precision Medicines, Inc.
PRAXUS stocksQuote delayed 15 min
10/27 上午06:49 updated
$267.39
+14.43+5.70%
Open
$256.36
High
$268.08
Low
$254.30
Volume
38.98萬
PRAX price history
-6.39%Open
285.65
Latest
267.39
High
295.51
Low
239.02
Average
266.17
Advertisement
Financial snapshot
PRAX - Praxis Precision Medicines, Inc.
EPS
-12.95USD
Forward EPS
-9.50USD
P/E
--
Forward P/E
-28.14x
P/B
5.57x
ROE
-38.86%
ROA
-25.65%
Operating margin
0.00%
Profit margin
0.00%
Revenue growth
--
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$96.90M | -$105.86M | -$97.04M | -$78.36M | -$76.07M |
| Net income | -$83.72M | -$92.56M | -$88.91M | -$73.93M | -$71.13M |
| Basic EPS | -2.87 | -3.20 | -3.50 | -3.36 | -3.31 |
| Diluted EPS | -2.87 | -3.20 | -3.50 | -3.36 | -3.31 |
Estimates vs actuals
Next earnings
2026-11-09
EPS estimate
-3.63
Revenue estimate
$0
Last surprise
+22.22%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-09 | -3.63 | Not reported | — |
| 2026-08-06 | -3.69 | -2.87 | +22.22% |
| 2026-05-07 | -3.68 | -3.20 | +13.01% |
| 2026-02-19 | -3.13 | -3.50 | -11.99% |
| 2025-11-05 | -3.49 | -3.36 | +3.72% |
| 2025-08-04 | -3.36 | -3.31 | +1.43% |
| 2025-05-02 | -3.21 | -3.29 | -2.46% |
| 2025-02-28 | -2.82 | -2.94 | -4.29% |
| 2024-11-06 | -1.95 | -2.75 | -40.94% |
| 2024-08-13 | -2.32 | -1.74 | +25.00% |
| 2024-05-13 | -2.16 | -2.84 | -31.48% |
| 2024-03-05 | -3.17 | -2.97 | +6.24% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $430.6M | 0.01% |
| STATE STREET CORP | 2026-06-30 | $343.7M | 0.01% |
| BlackRock Inc. | 2024-06-30 | $53.5M | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $6.3M | 0.00% |
| CITADEL ADVISORS LLC | 2026-06-30 | $2.5M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$650.00
Target range
$188.00 – $1201.00
Implied upside
143.09%
Strong buy
4
Buy
15
Hold
1
Sell
1
Strong sell
0
Advertisement